Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.

doi:10.1097/00126334-200412150-00022

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.

Journal of acquired immune deficiency syndromes (1999) - 15 Dec 2004

Derdelinckx Inge, Van Laethem Kristel, Maes Bart, Schrooten Yoeri, De Wit Stéphane, Florence Eric, Fransen Katrien, Ribas Sergio García, Marissens Denise, Moutschen Michel, Vaira Dolores, Zissis Georges, Van Ranst Marc, Van Wijngaerden Eric, Vandamme Anne-Mieke

Abstract excerpt

No abstract is available from the source.

Topics

Anti-HIV Agents
Drug Resistance, Viral
Female
HIV Infections
HIV-1
Humans
Male
Mutation
Reverse Transcriptase Inhibitors
Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 15577426
DOI: 10.1097/00126334-200412150-00022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics